Brief: Cizzle Biotechnology Announces LOI With Leading UK Clinical Diagnostic Group
Nov 5 (Reuters) - Cizzle Biotechnology Holdings PLC CIZ.L: CIZZLE BIOTECHNOLOGY - LOI WITH LEADING UK CLINICAL DIAGNOSTIC GROUP CIZZLE BIOTECHNOLOGY HOLDINGS PLC - LOI COVERS VERIFICATION OF CIZ1B BIOMARKER TEST WITH NHS FOUNDATION TRUST PARTNER Source text: ID:nRSE1967Ga Further company coverage: CIZ.L ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cizzle Biotechnology Holdings
See all newsRCS - Cizzle Biotechnology - Cizzle Shortlisted for One Nucleus Award 2026
Brief: Cizzle Biotechnology and Cizzle Bio Achieve CLIA Validation
Cizzle Biotechnology - Update on Launch of Lung Cancer Test in USA
Cizzle Biotechnology - Interim Results
Cizzle Biotechnology - Laboratory Expansion to Accelerate Sales in USA